BCL2 and type 1 diabetes mellitus: As a result, the onset and incidence of diabetes in three mouse models of T1D—multiple low-dose streptozotocin-induced diabetes, RIP-B7-1 mice, and non-obese diabetic (NOD) mice—were similar between wild-type and transgenic mice overexpressing Bcl-2 [139].